Table of Contents

company-logo

Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Xlucane, a ranibizumab biosimilar that is in Phase III clinical trials used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic related retinopathy, and retinal vein occlusion. Its pre-clinical phase products include Xcimzane for rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis and crohn diseases; Xoncane for acute lymphocytic leukemia; Spherotide for prostate cancer, breast cancer, endometriosis, and myoma; and Xdivane for melanoma, lung, head and throat, bladder, and urinary tract cancer, as well as for renal cell carcinoma. The company has a strategic biosimilar development partnership with STADA Arzneimittel AG to evaluate development and commercialization collaborations around its Xcimzane and Xdivane preclinical biosimilars. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden.

Xbrane Biopharma Dividend Announcement

• Xbrane Biopharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Xbrane Biopharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Xbrane Biopharma Dividend History

Xbrane Biopharma Dividend Yield

Xbrane Biopharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Xbrane Biopharma stock? Use our calculator to estimate your expected dividend yield:

Xbrane Biopharma Financial Ratios

P/E ratio-0.76
PEG ratio-0.06
P/B ratio1.09
ROE-131.15%
Payout ratio0.00%
Current ratio1.35
Quick ratio0.90
Cash Ratio0.06

Xbrane Biopharma Dividend FAQ

Does Xbrane Biopharma stock pay dividends?
Xbrane Biopharma does not currently pay dividends to its shareholders.
Has Xbrane Biopharma ever paid a dividend?
No, Xbrane Biopharma has no a history of paying dividends to its shareholders. Xbrane Biopharma is not known for its dividend payments.
Why doesn't Xbrane Biopharma pay dividends?
There are several potential reasons why Xbrane Biopharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Xbrane Biopharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Xbrane Biopharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Xbrane Biopharma a dividend aristocrat?
Xbrane Biopharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Xbrane Biopharma a dividend king?
Xbrane Biopharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Xbrane Biopharma a dividend stock?
No, Xbrane Biopharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Xbrane Biopharma stocks?
To buy Xbrane Biopharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Xbrane Biopharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.